https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-77362009-12-15 00:00:002019-02-15 08:46:08Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-12-01 / Cancer Treat. Rev. 2010 Apr;36(2):131-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-12-01 / Cancer Treat. Rev. 2010 Apr;36(2):131-412009-12-01 00:00:002019-02-15 08:53:00The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-12-01 / Endocr Metab Immune Disord Drug Targets 2009 Dec;9(4):328-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-12-01 / Endocr Metab Immune Disord Drug Targets 2009 Dec;9(4):328-432009-12-01 00:00:002019-02-15 08:44:08Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-04 / Vaccine 2009 Dec;28(2):542-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-04 / Vaccine 2009 Dec;28(2):542-72009-11-04 00:00:002019-02-15 08:44:10Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-902009-11-01 00:00:002009-11-01 00:00:00[The case of tumor escape mechanism by changing their tumor-associated antigens]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-822009-11-01 00:00:002019-02-15 08:48:32Heat-shock protein vaccines as active immunotherapy against human gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-62009-11-01 00:00:002009-11-01 00:00:00[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-14 / Biol. Blood Marrow Transplant. 2010 Mar;16(3):320-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-14 / Biol. Blood Marrow Transplant. 2010 Mar;16(3):320-322009-10-14 00:00:002019-02-15 08:50:56Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-152009-10-01 00:00:002019-02-15 08:49:26Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-182009-10-01 00:00:002019-02-15 08:44:11Dendritic cell-based cancer gene therapy
